Coronavirus (COVID-19) Advocacy
The ADA is lobbied Congress and the administration to protect dental patients and staff who are providing urgent and emergency care during the COVID-19 pandemic. The ADA is also lobbed to help dental practices stay viable during (and following) prolonged periods of reduced hours or closure. Visit ada.org to learn more about the Coronavirus (COVID-19) advocacy efforts.
Dentists’ role in monitoring, managing care of patients using buprenorphine
Jul 1, 2024
July JADA examines xerostomia, caries linked with use of drug
The possible connection between caries and buprenorphine should prompt dentists to teach patients about proper oral hygiene practices.
Read the full article.
